Ann: Lumos Achieves Key Phase 1 Milestone in Hologic Agreement, page-67

I'm hoping Doug and the board take what i requested on board and look into some on market purchases to show support to the company. Alot going on, however direct share purchase from their own pocket would be just as fruitful in my opinion as a buy back (a dollar is a dollar, right?)

We have the $5M coming in between now and end of next month which is big as we wont need any CR for some time.

$3.2Million cash available end of March.

Assume similar costs of $2.268Million for current quarter (could be less given less costs in product ramp in US)

Plus $5Million cash from second Hologic payment

$6.098Million in cash end of this quarter without any other product sales or services revenue.

So not much change from last quarter outside of further development with FFN and or other product sales/new product lines with other clients.